Cas no 127168-90-5 (methyl isoindoline-4-carboxylate;hydrochloride)
methyl isoindoline-4-carboxylate;hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- Methyl isoindoline-4-carboxylate hydrochloride
- METHYL ISOINDOLINE-4-CARBOXYLATE HCL
- methyl 2,3-dihydro-1H-isoindole-4-carboxylate,hydrochloride
- 4-(Methoxycarbonyl)isoindoline hydrochloride
- Methyl isoindoline-4-carboxylatehydrochloride
- methyl 2,3-dihydro-1H-isoindole-4-carboxylate hydrochloride
- ZEOILCADGXBXQW-UHFFFAOYSA-N
- SC2531
- RP07234
- 4-methoxycarbonylisoindoline hydrochloride
- SY096957
- AX8224430
- X9692
- ST24025485
- methylisoindoline-4-carboxylate hydrochlo
- methyl isoindoline-4-carboxylate;hydrochloride
- 2,3-dihydro-1h-isoindole-4carboxylic acid methyl ester hydrochloride salt
- DB-062565
- DTXSID10600398
- Methylisoindoline-4-carboxylatehydrochloride
- W-205267
- 1H-Isoindole-4-carboxylic acid, 2,3-dihydro-, methyl ester, hydrochloride (1:1)
- SCHEMBL6093232
- methyl 2,3-dihydro-1H-isoindole-4-carboxylate;hydrochloride
- EN300-1605887
- DS-17255
- SB66198
- Z3234811124
- 2,3-dihydro-1h-isoindole-4-carboxylic acid methyl ester hydrochloride salt
- Methyl 2,3-dihydro-1H-isoindole-4-carboxylate--hydrogen chloride (1/1)
- 127168-90-5
- MFCD10700133
- A848649
- AKOS015844700
-
- MDL: MFCD10700133
- Inchi: 1S/C10H11NO2.ClH/c1-13-10(12)8-4-2-3-7-5-11-6-9(7)8;/h2-4,11H,5-6H2,1H3;1H
- InChI Key: ZEOILCADGXBXQW-UHFFFAOYSA-N
- SMILES: Cl.O(C)C(C1=CC=CC2CNCC=21)=O
Computed Properties
- Exact Mass: 213.05600
- Monoisotopic Mass: 213.0556563g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 205
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 38.3
Experimental Properties
- Color/Form: White to Yellow Solid
- Boiling Point: 345.6°C at 760 mmHg
- Flash Point: 162.8°C
- PSA: 38.33000
- LogP: 2.20720
methyl isoindoline-4-carboxylate;hydrochloride Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P280;P305+P351+P338
- Storage Condition:Inert atmosphere,2-8°C
methyl isoindoline-4-carboxylate;hydrochloride Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
methyl isoindoline-4-carboxylate;hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | M173174-500mg |
methyl isoindoline-4-carboxylate;hydrochloride |
127168-90-5 | 97% | 500mg |
¥11662.90 | 2023-09-01 | |
| Fluorochem | 091749-10g |
Methyl isoindoline-4-carboxylate hydrochloride |
127168-90-5 | 95% | 10g |
£1657.00 | 2022-02-28 | |
| Alichem | A199010142-1g |
Methyl isoindoline-4-carboxylate hydrochloride |
127168-90-5 | 95% | 1g |
363.59 USD | 2021-06-01 | |
| Alichem | A199010142-5g |
Methyl isoindoline-4-carboxylate hydrochloride |
127168-90-5 | 95% | 5g |
1,161.30 USD | 2021-06-01 | |
| AstaTech | SC2531-0.25/G |
METHYL ISOINDOLINE-4-CARBOXYLATE HCL |
127168-90-5 | 95% | 0.25g |
$75 | 2023-09-15 | |
| AstaTech | SC2531-1/G |
METHYL ISOINDOLINE-4-CARBOXYLATE HCL |
127168-90-5 | 95% | 1g |
$199 | 2023-09-15 | |
| AstaTech | SC2531-5/G |
METHYL ISOINDOLINE-4-CARBOXYLATE HCL |
127168-90-5 | 95% | 5g |
$599 | 2023-09-15 | |
| Matrix Scientific | 070264-1g |
Methyl isoindoline-4-carboxylatehydrochloride, 95% |
127168-90-5 | 95% | 1g |
$1172.00 | 2023-09-09 | |
| Matrix Scientific | 070264-5g |
Methyl isoindoline-4-carboxylatehydrochloride, 95% |
127168-90-5 | 95% | 5g |
$3999.00 | 2023-09-09 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-EF161-100mg |
methyl isoindoline-4-carboxylate;hydrochloride |
127168-90-5 | 97+% | 100mg |
757.0CNY | 2021-07-12 |
methyl isoindoline-4-carboxylate;hydrochloride Related Literature
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
Additional information on methyl isoindoline-4-carboxylate;hydrochloride
Research Brief on Methyl Isoindoline-4-carboxylate Hydrochloride (CAS: 127168-90-5): Recent Advances and Applications
Methyl isoindoline-4-carboxylate hydrochloride (CAS: 127168-90-5) is a key intermediate in the synthesis of various biologically active compounds, particularly in the pharmaceutical and agrochemical industries. Recent studies have highlighted its significance in the development of novel therapeutic agents, owing to its unique structural properties and versatile reactivity. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, applications, and potential in drug discovery.
Recent advancements in synthetic chemistry have enabled more efficient and scalable routes for the production of methyl isoindoline-4-carboxylate hydrochloride. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an optimized catalytic process that significantly improves yield and purity, reducing production costs and environmental impact. This breakthrough is particularly relevant for large-scale pharmaceutical manufacturing, where cost-effectiveness and sustainability are critical considerations.
In the context of drug discovery, methyl isoindoline-4-carboxylate hydrochloride has emerged as a valuable scaffold for the design of kinase inhibitors. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported the successful incorporation of this moiety into a series of compounds targeting protein kinases involved in cancer progression. The results showed promising inhibitory activity against specific kinase isoforms, with potential applications in personalized cancer therapy. The study also highlighted the compound's favorable pharmacokinetic properties, such as improved solubility and bioavailability.
Beyond oncology, research has explored the use of methyl isoindoline-4-carboxylate hydrochloride in central nervous system (CNS) drug development. A recent publication in ACS Chemical Neuroscience (2023) described its utility as a precursor for neuroprotective agents targeting neurodegenerative diseases. The structural flexibility of the isoindoline core allows for modifications that enhance blood-brain barrier penetration, a critical factor in CNS drug design. Preliminary in vivo studies demonstrated reduced neuroinflammation and improved cognitive function in animal models of Alzheimer's disease.
The compound's applications extend to antimicrobial research as well. A 2024 study in the European Journal of Medicinal Chemistry reported the synthesis of novel antimicrobial agents derived from methyl isoindoline-4-carboxylate hydrochloride. These compounds exhibited potent activity against multidrug-resistant bacterial strains, with mechanisms of action distinct from existing antibiotics. This finding is particularly significant in light of the growing global threat of antimicrobial resistance.
In conclusion, methyl isoindoline-4-carboxylate hydrochloride (CAS: 127168-90-5) continues to be a molecule of significant interest in chemical biology and medicinal chemistry. Recent research has expanded our understanding of its synthetic accessibility and therapeutic potential across multiple disease areas. Future studies are expected to further explore its applications in targeted drug delivery systems and combination therapies, potentially leading to breakthrough treatments for challenging medical conditions.
127168-90-5 (methyl isoindoline-4-carboxylate;hydrochloride) Related Products
- 127168-94-9(Methyl 2-Benzylisoindoline-5-Carboxylate)
- 144055-26-5(Benzoic acid,2-[[4-(phenylmethyl)-1-piperazinyl]methyl]-, methyl ester)
- 127168-93-8(methyl isoindoline-5-carboxylate;hydrochloride)
- 27171-87-5(Methyl 2-(Dimethylamino)methylbenzoate)
- 5444-12-2(Methyl 3-(diethylaminomethyl)benzoate;hydrochloride)
- 127168-92-7(Methyl 2-benzylisoindoline-4-carboxylate)
- 775545-06-7(Methyl Isoindoline-4-carboxylate)
- 61088-45-7(methyl 2-(aminomethyl)benzoate)
- 849020-92-4(2-Carbomethoxybenzylamine Hydrochloride)
- 742666-57-5(methyl isoindoline-5-carboxylate)